Edition:
India

Galmed Pharmaceuticals Ltd (GLMD.OQ)

GLMD.OQ on NASDAQ Stock Exchange Capital Market

6.08USD
26 Apr 2018
Change (% chg)

$0.06 (+1.00%)
Prev Close
$6.02
Open
$6.08
Day's High
$6.08
Day's Low
$6.08
Volume
200
Avg. Vol
17,927
52-wk High
$12.00
52-wk Low
$3.61

Select another date:

Tue, Apr 3 2018

BRIEF-Galmed Pharmaceuticals Files For Mixed Shelf Of Upto $150 Mln

* GALMED PHARMACEUTICALS LTD FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING Source text: [https://bit.ly/2G8U5GO] Further company coverage:

BRIEF-Galmed Pharmaceuticals Q4 Loss Per Share $0.27

* GALMED PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Galmed Announces Arrive Study Data

* TOP-LINE RESULTS FROM ARRIVE TRIAL DID NOT MEET ITS PRIMARY ENDPOINT

BRIEF-Galmed Pharmaceuticals To Provide Corporate Update At The Leerink Partners 7Th Annual Global Healthcare Conference

* GALMED PHARMACEUTICALS TO PROVIDE CORPORATE UPDATE AT THE LEERINK PARTNERS 7TH ANNUAL GLOBAL HEALTHCARE CONFERENCE Source text for Eikon: Further company coverage:

BRIEF-Israeli Tax Authority Issues Tax Ruling On Galmed Pharma's Unit

* GALMED PHARMACEUTICALS -ISRAELI TAX AUTHORITY ISSUED TAX RULING GRANTING CO'S UNIT "PREFERRED TECHNOLOGICAL ENTERPRISE" STATUS, SUBJECT TO CONDITIONS

BRIEF-Galmed Pharma Raised Gross Proceeds Of $11.6 Mln Under ATM Programs During Dec. 2017

* GALMED PHARMACEUTICALS RAISED GROSS PROCEEDS OF $11.6 MILLION UNDER ATM PROGRAMS DURING DECEMBER 2017 Source text for Eikon: Further company coverage:

BRIEF-683 Capital Management Llc Reports 5.1 Pct Passive Stake In Galmed Pharmaceuticals Ltd As Of Dec 6

* 683 CAPITAL MANAGEMENT LLC REPORTS 5.1 PERCENT PASSIVE STAKE IN GALMED PHARMACEUTICALS LTD AS OF DEC 6 - SEC FILING Source text: (http://bit.ly/2oG4CRl) Further company coverage:

BRIEF-Galmed Pharmaceuticals Q3 loss per share $0.23

* Galmed Pharmaceuticals reports third quarter 2017 financial results and provides business update

Select another date: